Evidence map›Paper›PMID 41151067›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Epidemiology of childhood leukemia in Mexico and Latin America: Effects of vulnerability and social justice].

Juan Carlos Núñez-Enríquez, Rosana Pelayo, Janet Flores-Lujano, Aldo Allende-López, Erika Alarcón-Ruiz, David Aldebarán Duarte-Rodríguez, Ana Karen Rodríguez-Muñoz, Roberto Rodríguez-Díaz, Omar Chávez-Martínez, Juan Manuel Mejía-Aranguré

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan Carlos Núñez-EnríquezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría "Dr. Silvestre Frenk Freund", División de Investigación en Salud. Ciudad de México, México.ORCID 0000-0002-8070-9727
Rosana PelayoInstituto Mexicano del Seguro Social, Unidad de Educación e Investigación en Salud. Ciudad de México, México.ORCID 0000-0003-3401-9757
Janet Flores-LujanoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría "Dr. Silvestre Frenk Freund", Unidad de Investigación Médica en Epidemiología Clínica. Ciudad de México, México.ORCID 0000-0003-0727-2837
Aldo Allende-LópezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría "Dr. Silvestre Frenk Freund", Unidad de Investigación Médica en Epidemiología Clínica. Ciudad de México, México.ORCID 0000-0001-6592-5491
Erika Alarcón-RuizTecnológico Nacional de México, Instituto Tecnológico de Ciudad de Madero, División de Estudios de Posgrado e Investigación. Ciudad Madero, Tamaulipas, México.ORCID 0000-0002-7104-6108
David Aldebarán Duarte-RodríguezInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Desarrollo de la Investigación. Ciudad de México, México.ORCID 0000-0002-0560-2540
Ana Karen Rodríguez-MuñozUniversidad Nacional Autónoma de México, Facultad de Estudios Superiores Iztacala. Ciudad de México, México.ORCID 0000-0003-1700-2208
Roberto Rodríguez-DíazUniversidad Nacional Autónoma de México, Facultad de Medicina. Ciudad de México, México.ORCID 0000-0002-8725-9677
Omar Chávez-MartínezInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Investigación Clínica. Ciudad de México, México.ORCID 0000-0003-2633-1898
Juan Manuel Mejía-AranguréInstituto Nacional de Medicina Genómica, Laboratorio de Genómica Funcional del Cáncer. Ciudad de México, México.ORCID 0000-0001-8027-6231

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute leukemia (AL) is the most common malignancy in children in Mexico and Latin America, where high incidence and mortality rates are observed, particularly among populations with indigenous ancestry and unfavorable socioeconomic conditions. This article examines the social and biological determinants that influence the onset and progression of acute lymphoblastic leukemia (ALL), highlighting the Greaves and Kinlen hypotheses and their potential relevance in Latin American contexts. Evidence suggests that factors such as poverty, educational disadvantage, overcrowding, and limited access to healthcare directly affect childhood mortality from AL. In the analysis conducted specifically for this study, using publicly available open-access databases, a poverty-mortality gradient was identified, showing that the poorest municipalities face a higher risk of leukemia-related death in individuals under 20 years of age. The study concludes that epidemiology, when integrated with principles of social justice, is essential for designing and monitoring public policy interventions aimed at reducing inequalities and improving childhood survival in Mexico.

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaSocial JusticeSocial VulnerabilityAdolescentChildChild, PreschoolFemaleHumansIncidenceInfantLatin AmericaMaleMexicoPovertySocioeconomic FactorsYoung AdultChild HealthEpidemiologíaEpidemiologyHealth InequitiesInequidades en SaludLeucemiaLeukemiaSalud InfantilSocial VulnerabilityVulnerabilidad Social

Identifiers

PMID41151067
PMCPMC12774443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.